MLTX Competitors & Alternatives

Compare MoonLake Immunotherapeutics with similar stocks in the same industry

Biotechnology

MLTX

Main Stock
$11.85
-5.20%
Tradestie Score
33
Market Cap
$448.32M
Analyst Upside
+155.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: nanobody technology, IL-17A/F inhibition
Major Customers 3
patients with inflammatory diseases healthcare providers clinical trial sites
Critical Suppliers 2
contract manufacturing organizations CROs for clinical trials
Direct Ecosystem Rivals 3

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ELVN Enliven Therapeutics, Inc. Common Stock
$47.74
-2.18%
$1.17B - 34 Compare
INVA Innoviva, Inc. Common Stock
$18.59
-2.34%
$1.15B 8.1 54 Compare
TRVI Trevi Therapeutics, Inc. Common Stock
$13.30
-2.56%
$1.14B - 42 Compare
ORIC Oric Pharmaceuticals, Inc. Common Stock
$7.69
-2.23%
$1.14B - 45 Compare
MAZE Maze Therapeutics, Inc. Common Stock
$34.16
-0.50%
$1.13B - 32 Compare
WVE Wave Life Sciences Ltd. Ordinary Shares
$2.89
-7.82%
$1.12B - 32 Compare
NKTR Nektar Therapeutics
$36.57
-1.88%
$1.12B - 59 Compare
PRAX Praxis Precision Medicines, Inc. Common Stock
$309.08
-5.81%
$1.12B - 30 Compare
IMTX Immatics N.V. Ordinary Shares
$6.22
-2.74%
$1.09B - 38 Compare
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares
$12.58
-0.16%
$1.05B 39.4 35 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry